CINECA IRIS Institutional Research Information System

GIORDANO, MIRELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.152
EU - Europa 637
AS - Asia 144
AF - Africa 109
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 2.045
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.137
SE - Svezia 194
IT - Italia 159
DE - Germania 126
CI - Costa d'Avorio 66
CN - Cina 64
BG - Bulgaria 43
AT - Austria 34
SG - Singapore 32
GB - Regno Unito 28
VN - Vietnam 25
NG - Nigeria 21
SN - Senegal 21
CA - Canada 15
IN - India 12
RU - Federazione Russa 12
FR - Francia 9
PL - Polonia 9
FI - Finlandia 8
BE - Belgio 6
HK - Hong Kong 5
UA - Ucraina 4
EU - Europa 2
LU - Lussemburgo 2
TR - Turchia 2
BR - Brasile 1
CH - Svizzera 1
EG - Egitto 1
IL - Israele 1
JP - Giappone 1
NL - Olanda 1
PK - Pakistan 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 2.045
Salva come PNG Salva come JPEG
Città #
Chandler 196
Fairfield 146
Woodbridge 137
Houston 84
Abidjan 66
Ashburn 61
Seattle 57
Cambridge 53
Wilmington 49
Pisa 48
Sofia 43
Beijing 40
Princeton 38
Bremen 37
Lawrence 34
Florence 30
Vienna 28
Ann Arbor 26
Dakar 21
Lagos 21
Serra 21
Medford 19
Milan 18
San Diego 17
Boulder 15
London 15
Ottawa 15
Frankfurt am Main 14
Des Moines 12
Nanjing 9
Washington 9
Dong Ket 8
Warsaw 8
Falls Church 7
Brussels 5
Redmond 4
Nanchang 3
Nürnberg 3
Phoenix 3
Cologno Monzese 2
Hangzhou 2
Hebei 2
Jiaxing 2
Lancaster 2
Luxembourg 2
Modugno 2
Moncalieri 2
Norwalk 2
Pistoia 2
Redwood City 2
Verona 2
Vitry-sur-seine 2
Adria 1
Amsterdam 1
Bhavnagar 1
Boardman 1
Boydton 1
Cairo 1
Cascina 1
Central 1
Chicago 1
Cluj-napoca 1
Council Bluffs 1
Dearborn 1
Düsseldorf 1
Fremont 1
Genova 1
Haikou 1
Hanover 1
Helsinki 1
Indore 1
Islamabad 1
Jinan 1
Kowloon 1
Kraków 1
Kunming 1
Los Angeles 1
New York 1
Noale 1
Oxford 1
Ragusa 1
Riyadh 1
San Miniato Basso 1
San Vincenzo 1
San Zeno Di Montagna 1
Seacroft 1
Shanghai 1
Shenyang 1
São Paulo 1
Tel Aviv 1
Tianjin 1
Tokyo 1
Turin 1
Zurich 1
Totale 1.488
Salva come PNG Salva come JPEG
Nome #
Aberrant expression of anaplastic lymphoma kinase in lung adenocarcinoma: Analysis of circulating free tumor RNA using one-step reverse transcription-polymerase chain reaction 126
C-MYC, HIF-1α, ERG, TKT, and GSTP1: an Axis in Prostate Cancer? 124
EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center 124
Small cell lung cancer transformation and the T790M mutation: A case report of two acquired mechanisms of TKI resistance detected in a tumor rebiopsy and plasma sample of EGFR-mutant lung adenocarcinoma 119
null 116
Distinct Angiogenic microRNA-mRNA Expression Profiles Among Subtypes of Lung Adenocarcinoma. 109
null 98
Papillary Thyroid Carcinoma With Rare exon 15 BRAF Mutation Has Indolent Behavior: A Single-Institution Experience 93
Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis 81
Expression profiling and microRNA regulation of the LKB1 pathway in young and aged lung adenocarcinoma patients 80
null 78
Role of microRNA-33a in regulating the expression of PD-1 in lung adenocarcinoma. 72
Differential microRNA expression profiles between young and old lung adenocarcinoma patients. 59
Immune Profiling of Deficient Mismatch Repair Colorectal Cancer Tumor Microenvironment Reveals Different Levels of Immune System Activation 58
Differential microRNA Expression Profile between Young and Old Lung Adenocarcinoma Patients. 51
Expression Profiling of LKB1 Pathway in Young and Old Lung Adenocarcinoma Patients. 49
Tumor Regression Grading Assessment in Locally Advanced Pancreatic Cancer After Neoadjuvant FOLFIRINOX: Interobserver Agreement and Prognostic Implications 43
Feasibility of BRCA1/2 testing of formalin-fixed and paraffin-embedded pancreatic tumor samples: A consecutive clinical series 41
Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness 37
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial 36
Molecular Pathology of Acinar Cystic Transformation 34
Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study 33
Molecular Pathology of Intraductal Papillary Mucinous Neoplasms 33
Exploring clinical and gene expression markers of benefit from FOLFOXIRI/bevacizumab in patients with BRAF-mutated metastatic colorectal cancer: Subgroup analyses of the TRIBE2 study 33
Molecular Pathology of Neuroendocrine Carcinoma 31
Early modulation of Angiopoietin-2 plasma levels predicts benefit from regorafenib in patients with metastatic colorectal cancer 31
Prognostic and predictive impact of consensus molecular subtypes and CRCAssigner classifications in metastatic colorectal cancer: a translational analysis of the TRIBE2 study 30
Molecular Pathology of Neuroendocrine Tumors 30
Molecular Pathology of Mucinous Cystic Neoplasms 30
Molecular Pathology of Acinar Cell Carcinoma 30
Expression of miRNA-25 in young and old lung adenocarcinoma 26
Prognostic role of TPL2 in early‑stage non‑small cell lung cancer 25
Molecular Pathology of Solid Pseudopapillary Neoplasms 19
Molecular Pathology of Serous Cystic Neoplasms 19
Molecular Pathology of Pancreatic Intraepithelial Neoplasms 17
Molecular Pathology of Pancreatic Ductal Adenocarcinoma 17
Trop-2 and Nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs' development 17
P2X7 mRNA expression in non-small cell lung cancer: MicroRNA regulation and prognostic value 16
Molecular Subtypes of Pancreatic Ductal Adenocarcinoma 16
Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience 15
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases 14
Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study by GONO 10
Dynamic profiling of the immune tumor microenvironment in locally advanced gastric cancer treated with perioperative chemotherapy 8
Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study 5
An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer 3
Totale 2.136
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.598
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.598
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019134 0 0 0 3 4 5 31 7 3 19 36 26
2019/2020395 37 21 21 25 47 37 52 32 35 39 40 9
2020/2021170 12 16 7 2 17 16 5 20 16 17 6 36
2021/2022336 5 7 2 4 37 75 18 17 20 33 27 91
2022/2023751 80 107 45 77 69 75 7 50 171 5 55 10
2023/2024129 27 41 60 1 0 0 0 0 0 0 0 0
Totale 2.136